Subcortical Arousal in Perceptual Awareness

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT06934356
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
13 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • EEG — DEVICE
    Participants will have scalp EEG recorded with the international 10-20 system sampled at 256Hz using EEG amplifiers for purposes of surface event related potential analysis
  • Eye Tracking — DEVICE
    An eye-tracking device may be used during the perceptual awareness task. Pupillary and gaze location measurements are recorded using either a ViewPoint\~VoltagePro.EyeLink 1000 Plus system, or Argus Science ETVision system. If using the ViewPoint\~VoltagePro system or the Argus Science ETVision system, participants will be asked to wear an eye tracker during the perceptual awareness task (similar to wearing sunglasses). If using the EyeLink 1000 Plus system, participants may be asked to place their head inside of a padded head-chin rest to stabilize head position
  • Behavioral task — DEVICE
    For the visual perceptual awareness task, the participant will be presented with barely perceptible visual stimuli. After a variable delay, the participant will be asked to report perception of each stimulus and identify its location.
  • fMRI — DIAGNOSTIC_TEST
    Visual, auditory or tactile behavioral task will be performed during fMRI at the Yale MR Center. The subject will be asked to lie still in a 3T magnet scanner for up to 15-minute blocks. Each subject will have a sagittal T1-weighted localizer scan (3 minutes) and axial-oblique T1-weighted images (3 min). Multiple 5-15-minute imaging runs will be repeated up to 10 times. The subjects' responses will be recorded by a computer that is linked to the button box. The stimuli will be presented in blocks of 5 to 15 minutes throughout the MR imaging sequences.

Study Details

The study consists of prospective enrollment of healthy participants and patients with epilepsy, as well as analysis of an existing data set. Healthy participants will be studied with fMRI, eye metrics and behavioral testing at Yale. Patients will be studied with intracranial thalamic and cortical recording and stimulation, eye metrics and behavioral testing.

Key Dates

Start date
Oct 13, 2025
Status verified
Jun 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
202 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intracranial Thalamic and Cortical Recording (Aim 3A)
    Participants will perform the visual behavioral task with intracranial electroencephalogram (EEG) brain recordings carried out in parallel with surface EEG recordings. For Aim 3A, we will analyze thalamic event related potentials in perceived vs not perceived stimuli, classified as in perception of no report visual stimuli based on eye metrics.
  • Experimental: Thalamic Stimulation (Aim 3B)
    We will test participants during the Visual Report Paradigm, while recording from the intralaminar thalamus with simultaneous scalp EEG as in Aim 3A. Three thalamic stimulation conditions will be tested, randomized across trials: 1. No stimulation; 2. Stimulation Concurrent with visual stimuli; 3. Stimulation Delayed to 2s after visual stimuli. Stimulation will be a 100Hz train lasting 300ms, with biphasic square wave pulses 120μs per phase, current adjusted previously by clinicians to maximum tolerated level without side effects (typically \~3mA). The electrical stimulation is being delivered for research purposes to understand the causal role of thalamus in regulating visual perception.
  • Experimental: fMRI with report + no-report perception paradigms (Aims 1 and 2)
    Participants will consist of healthy adults undergoing fMRI, eye metric and behavioral testing with report + no-report perception paradigms. This will include prospective data collection for the auditory paradigm, tactile paradigm, as well as analysis of an existing data set for the visual paradigm.

Primary Outcome Measure

Subcortical event-related signals [ Time Frame: Immediately after the intervention ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Yale School of MedicineNew HavenConnecticut06520
Francois Stockart
Hal Blumenfeld, MD, PhD (PRINCIPAL_INVESTIGATOR)
Imran Quraishi, MD, PhD (SUB_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66160
Laura Crabtree
Utku Uysal, MD, MS (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Erin Kaye Donahue, PhD
Mark Richardson, MD, PhD (PRINCIPAL_INVESTIGATOR)
Peter Hadar, MD (SUB_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55901
Jamie Van Gompel, MD (PRINCIPAL_INVESTIGATOR)
Dartmouth Hitchcock Medical CenterLebanonNew Hampshire03756
Anastasia Kanishcheva, MPH
Barbara Jobst, MD (PRINCIPAL_INVESTIGATOR)
University of Pittsburgh Medical CenterPittsburghPennsylvania15260
Alexandra Urban, MD (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical CenterNashvilleTennessee37235
Dario Englot, MD, PhD (PRINCIPAL_INVESTIGATOR)
Baylor College of MedicineHoustonTexas77030
Victoria Gates
Sameer Anil Sheth, MD, PhD (PRINCIPAL_INVESTIGATOR)
Vaishnav Krishnan, MD, PhD (SUB_INVESTIGATOR)

Find similar trials in New Haven, CT

By condition

Related Studies